Skip to main content

Advertisement

SpringerLink
Log in

Late-Onset EBV Susceptibility and Refractory Pure Red Cell Aplasia Revealing DADA2

  • Letter to Editor
  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 3
Fig. 1
Fig. 2
Fig. 4

References

  1. Meyts I, Aksentijevich I. Deficiency of adenosine deaminase 2 (DADA2): updates on the phenotype, genetics, pathogenesis, and treatment. J Clin Immunol. 2018;38:569–78.

    Article  CAS  Google Scholar 

  2. Trotta L, Martelius T, Siitonen T, Hautala T, Hämäläinen S, Juntti H, et al. ADA2 deficiency: clonal lymphoproliferation in a subset of patients. J Allergy Clin Immunol. 2018;141:1534–1537.e8.

    Article  Google Scholar 

  3. Alabbas F, Elyamany G, Alsharif O, Hershfield M, Meyts I. Childhood Hodgkin lymphoma: think DADA2. J Clin Immunol. 2019;39:26–9.

    Article  Google Scholar 

  4. Latour S, Fischer A. Signaling pathways involved in the T-cell-mediated immunity against Epstein-Barr virus: lessons from genetic diseases. Immunol Rev. 2019;291:174–89.

    Article  CAS  Google Scholar 

  5. Zavialov AV, Gracia E, Glaichenhaus N, Franco R, Zavialov AV, Lauvau G. Human adenosine deaminase 2 induces differentiation of monocytes into macrophages and stimulates proliferation of T helper cells and macrophages. J Leukoc Biol. 2010;88:279–90.

    Article  CAS  Google Scholar 

  6. Kaljas Y, Liu C, Skaldin M, Wu C, Zhou Q, Lu Y, et al. Human adenosine deaminases ADA1 and ADA2 bind to different subsets of immune cells. Cell Mol Life Sci CMLS. 2017;74:555–70.

    Article  CAS  Google Scholar 

  7. Arts K, Bergerson JRE, Ombrello AK, Similuk M, Oler AJ, Agharahimi A, et al. Warts and DADA2: a mere coincidence? J Clin Immunol. 2018;38:836–43.

    Article  Google Scholar 

  8. Ulirsch JC, Verboon JM, Kazerounian S, Guo MH, Yuan D, Ludwig LS, et al. The genetic landscape of Diamond-Blackfan anemia. Am J Hum Genet. 2018;103:930–47.

    Article  CAS  Google Scholar 

  9. Hashem H, Kumar AR, Müller I, Babor F, Bredius R, Dalal J, et al. Hematopoietic stem cell transplantation rescues the hematological, immunological, and vascular phenotype in DADA2. Blood. 2017;130:2682–8.

    Article  CAS  Google Scholar 

  10. Hashem H, Egler R, Dalal J. Refractory pure red cell aplasia manifesting as deficiency of adenosine deaminase 2. J Pediatr Hematol Oncol. 2017;39:e293–6.

    Article  Google Scholar 

  11. Rosain J, Oleaga-Quintas C, Deswarte C, Verdin H, Marot S, Syridou G, et al. A variety of Alu-mediated copy number variations can underlie IL-12Rβ1 deficiency. J Clin Immunol. 2018;38:617–27.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Hôpital Estaing, 1 Place Lucie Aubrac, 63000, Clermont-Ferrand, France

    Tom Le Voyer & Guillaume Le Guenno

  2. Department of Clinical Immunology, Hôpital Saint-Louis- AP-HP, 1 av Claude Vellefaux, 75010, Paris, France

    David Boutboul

  3. Laboratory of Lymphocyte Activation and Susceptibility to EBV infection, Imagine Institute - Inserm UMR 1163, Paris, France

    David Boutboul & Sylvain Latour

  4. Department Pathology, Hôpital Estaing, Clermont-Ferrand, France

    Albane Ledoux-Pilon

  5. Hematology Stem Cell Transplant Unit, Saint Louis Hospital, APHP, Paris, France

    Flore Sicre de Fontbrune

  6. Department of Medical Genetics, Rare Diseases and Personalized Medicine, University of Montpellier, CEREMAIA, CHU Montpellier, Montpellier, France

    Guilaine Boursier

Authors
  1. Tom Le Voyer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David Boutboul
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Albane Ledoux-Pilon
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Flore Sicre de Fontbrune
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Guilaine Boursier
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Sylvain Latour
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Guillaume Le Guenno
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

T. L. V. and D. B wrote the manuscript. G. L. G and F. S. contributed to the patient recruitment and management. D. B. and S. L. performed the exome analysis. G. B. performed identification of the large deletion and intra-familial segregation analysis. A. L. reviewed pathological specimen. D. B., S. L., and G. L. G supervised the project. All the authors reviewed the manuscript.

Corresponding authors

Correspondence to David Boutboul or Guillaume Le Guenno.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Le Voyer, T., Boutboul, D., Ledoux-Pilon, A. et al. Late-Onset EBV Susceptibility and Refractory Pure Red Cell Aplasia Revealing DADA2. J Clin Immunol 40, 948–953 (2020). https://doi.org/10.1007/s10875-020-00812-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10875-020-00812-8

Search

Navigation